![Seong-Ho Choi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seong-Ho Choi currently works at Double Investment Co. Ltd., as Chief Executive Officer.
Mr. Choi also formerly worked at VGXI, Inc., as Auditor.
Mr. Choi received his graduate degree from The University of Seoul.
| Empresas | Cargo | Inicio |
|---|---|---|
Double Investment Co. Ltd. | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| GENEONE LIFE SCIENCE, INC. | Comptroller/Controller/Auditor | 12/08/2025 |
VGXI, Inc.
 VGXI, Inc. Pharmaceuticals: MajorHealth Technology Manufactures deoxyribonucleic acid plasmids for human clinical trials | Comptroller/Controller/Auditor | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
GeneOne Life Science, Inc.
 GeneOne Life Science, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
The University of Seoul
 The University of Seoul Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VGXI, Inc.
VGXI, Inc. Pharmaceuticals: MajorHealth Technology Manufactures deoxyribonucleic acid plasmids for human clinical trials | Health Technology |
Double Investment Co. Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
